Revenue | ₹94.65Cr |
Net Profits | ₹16.09Cr |
Net Profit Margins | 17.00% |
Novartis India Ltd’s revenue fell -8.64% since last year same period to ₹94.65Cr in the Q3 2025-2026. On a quarterly growth basis, Novartis India Ltd has generated -5.09% fall in its revenue since last 3-months.
Novartis India Ltd’s net profit fell -36.78% since last year same period to ₹16.09Cr in the Q3 2025-2026. On a quarterly growth basis, Novartis India Ltd has generated -33.57% fall in its net profits since last 3-months.
Novartis India Ltd’s net profit margin fell -30.8% since last year same period to 17.00% in the Q3 2025-2026. On a quarterly growth basis, Novartis India Ltd has generated -30% fall in its net profit margins since last 3-months.
The revenue for Novartis India Ltd in the Q3 results 2025 was ₹94.65Cr.
The net profit for Novartis India Ltd in the Q3 results 2025 was ₹16.09Cr.
The net profit margin for Novartis India Ltd in the Q3 results 2025 was 17.00%.
The revenue for Novartis India Ltd in the Q3 results 2024 was ₹103.60Cr.
The net profit for Novartis India Ltd in the Q3 results 2024 was ₹25.45Cr.
The net profit margin for Novartis India Ltd in the Q3 results 2024 was 24.57%.